Crown of head hair loss is a common concern affecting both men and women, ranging from gradual thinning linked to genetics to sudden shedding caused by medical conditions. Understanding the underlying cause is essential, as treatment options and outcomes vary considerably. This article explores the most frequent causes of crown hair loss, explains when to seek medical advice, outlines how diagnosis is approached within the NHS, and summarises the evidence-based treatments and lifestyle measures available in the UK to help manage and slow progression.

Common Causes of Hair Loss at the Crown of the Head

Androgenetic alopecia is the most common cause of crown hair loss, driven by DHT-related follicle miniaturisation, though telogen effluvium, alopecia areata, scarring alopecias, nutritional deficiencies, thyroid disorders, and certain medications can also be responsible.

Not sure if this is normal? Chat with one of our pharmacists →

Hair loss at the crown of the head is one of the most frequently reported patterns of hair thinning in both men and women, and it can arise from a range of underlying causes. Understanding the likely cause is the first step towards appropriate management.

Androgenetic alopecia (also known as male- or female-pattern hair loss) is by far the most common cause. In men, this typically presents as a receding hairline combined with thinning at the crown, eventually merging into a broader bald patch. In women, the pattern tends to involve diffuse thinning across the crown and top of the scalp, with the frontal hairline often preserved. This condition is driven by a genetic sensitivity to dihydrotestosterone (DHT), a derivative of testosterone that causes hair follicles to miniaturise over time.

Other notable causes include:

• Telogen effluvium — a temporary, diffuse shedding often triggered by physical or emotional stress, illness, surgery, significant weight loss, or the postpartum period. Hair typically regrows once the trigger is resolved.

• Alopecia areata — an autoimmune condition in which the immune system mistakenly attacks hair follicles, sometimes producing a distinct bald patch at the crown.

• Traction alopecia — caused by persistent tension on the hair from tight hairstyles such as braids, buns, or extensions; the crown and hairline are commonly affected and early recognition is important to prevent permanent damage.

• Scarring alopecias — a group of conditions, including lichen planopilaris (LPP) and central centrifugal cicatricial alopecia (CCCA), in which inflammation destroys follicles and can cause irreversible hair loss. These require prompt specialist assessment.

• Nutritional deficiencies — iron deficiency (reflected by low ferritin) and zinc deficiency can contribute to hair thinning, particularly in women. The role of vitamin D is less certain and the evidence remains inconsistent; testing and medical guidance are advisable before starting supplements.

• Medication-related hair loss — a number of medicines, including retinoids, anticoagulants, antithyroid drugs, sodium valproate, and some chemotherapy agents, can cause hair loss. If you have recently started a new medicine, discuss this with your GP.

• Thyroid disorders — both hypothyroidism and hyperthyroidism can cause diffuse hair loss that may be most noticeable at the crown.

• Scalp conditions — such as seborrhoeic dermatitis or tinea capitis (scalp ringworm). Tinea capitis is more common in children, is contagious, and can cause scarring if untreated; early systemic antifungal treatment is required.

It is worth noting that some degree of hair thinning at the crown is a normal part of ageing for many people and does not always indicate an underlying medical problem.

When to See a GP About Crown Hair Loss

See your GP promptly if hair loss is sudden, occurs in clumps, is accompanied by scalp inflammation or pain, or is associated with systemic symptoms such as fatigue or hormonal changes, as these may indicate a treatable or urgent underlying condition.

Many people experiencing crown of head hair loss are understandably concerned, and whilst gradual thinning associated with androgenetic alopecia is generally not a medical emergency, there are certain circumstances in which it is important to seek professional advice promptly.

You should contact your GP if:

• Hair loss is sudden or occurs in large clumps rather than gradually

• You notice distinct bald patches, particularly if they are circular or irregular in shape

• The scalp appears red, scaly, inflamed, or itchy alongside hair loss

• You experience pain, burning, or tenderness of the scalp, or notice that follicular openings appear to be disappearing — these may be signs of a scarring alopecia requiring urgent dermatology assessment

• Hair loss is accompanied by other symptoms such as unexplained fatigue, weight changes, or irregular periods (in women)

• You are losing hair from other parts of the body, including eyebrows or eyelashes

• Hair loss begins after starting a new medication — do not stop any prescribed medicine without first speaking to your GP

• You are a child or teenager experiencing noticeable crown thinning; in children, broken hairs, 'black dot' patches, scalp scaling, or swollen lymph nodes near the scalp may suggest tinea capitis, which needs prompt treatment

For women, hair loss at the crown that develops rapidly or is associated with signs of hormonal imbalance — such as acne, increased facial hair, or menstrual irregularities — warrants prompt assessment to rule out conditions such as polycystic ovary syndrome (PCOS) or adrenal disorders.

It is also reasonable to see your GP if hair loss is causing significant psychological distress, even if no underlying medical cause is suspected. The NHS recognises that hair loss can have a considerable impact on self-esteem and mental wellbeing, and your GP can discuss referral options, including to a dermatologist or trichologist, as appropriate. Your GP can also signpost you to NHS psychological support services if needed. Early assessment is generally preferable, as some causes of crown hair loss respond better to treatment when identified early.

How Crown Hair Loss Is Diagnosed in the UK

Diagnosis begins with a GP consultation including medical history, scalp examination, and targeted blood tests such as full blood count, serum ferritin, and thyroid function tests; specialist referral for trichoscopy or scalp biopsy may follow if the cause remains unclear.

Diagnosing the cause of crown of head hair loss typically begins with a thorough consultation with a GP, who will take a detailed medical and family history, review any current medications, and examine the pattern and extent of hair loss on the scalp. Investigations are guided by the clinical picture rather than performed routinely.

Blood tests are commonly requested to exclude reversible medical causes. Typical first-line tests include:

• Full blood count (to check for anaemia)

• Serum ferritin and iron studies

• Thyroid function tests (TFTs)

Additional tests may be considered selectively based on symptoms and examination findings:

• Vitamin D and B12 levels (if deficiency is clinically suspected)

• Hormone profile in women with features of hyperandrogenism (such as irregular periods or increased facial hair), including testosterone, sex hormone-binding globulin (SHBG) to calculate the free androgen index, LH, and FSH; prolactin is measured if clinically indicated

• Inflammatory markers if an autoimmune cause is suspected

If tinea capitis is suspected — particularly in children — mycological microscopy and culture of scalp scrapings or hair samples should be performed.

In some cases, a trichoscopy — a non-invasive dermoscopic examination of the scalp — may be performed to assess follicle density and miniaturisation patterns. This technique is particularly useful in distinguishing androgenetic alopecia from other conditions such as alopecia areata.

If the diagnosis remains unclear or the hair loss is severe, your GP may refer you to a consultant dermatologist via the NHS. In specialist settings, a scalp biopsy may occasionally be recommended to examine follicle structure under a microscope, particularly when scarring alopecia (which can permanently destroy follicles) is suspected.

Private trichology clinics are also available in the UK, though these are not NHS-funded. The Institute of Trichologists and the Trichological Society maintain registers of qualified practitioners. It is important to be aware that trichologists are not regulated by statute in the UK and cannot prescribe medicines on the NHS. Definitive diagnosis and any prescribing should be undertaken by a GMC-registered clinician such as your GP or a dermatologist.

Evidence-Based Treatments Available in the UK

Minoxidil (topical) and finasteride (oral, men only) are the main licensed treatments for androgenetic alopecia in the UK; treatment of any identified underlying cause, such as a nutritional deficiency or thyroid disorder, can also lead to hair regrowth.

Treatment for crown of head hair loss depends entirely on the underlying cause. Where a reversible cause such as a nutritional deficiency or thyroid disorder is identified, treating the root condition will often lead to hair regrowth over several months. For androgenetic alopecia — the most common cause — several evidence-based options are available.

Minoxidil is the only topical treatment currently licensed in the UK for both male and female pattern hair loss. Available over the counter as a 2% or 5% solution or foam (the generic name is minoxidil; branded products are available), the precise mechanism by which it reduces hair loss is not fully understood, though it is thought to prolong the growth phase of the hair cycle. It must be applied consistently to the crown and affected areas according to the pack directions, and results typically take three to six months to become apparent. An initial increase in shedding during the first few weeks is common and usually temporary. Hair loss may resume if treatment is stopped. Common side effects include scalp irritation and, occasionally, unwanted facial hair growth (hypertrichosis). Minoxidil should not be used during pregnancy or whilst breastfeeding. If you experience significant irritation or other concerning effects, stop use and seek medical advice. Suspected side effects can be reported via the MHRA Yellow Card scheme at yellowcard.mhra.gov.uk or via the Yellow Card app.

Experiencing these side effects? Our pharmacists can help you navigate them →

Finasteride (1 mg daily) is a prescription-only oral medicine licensed for men only in the UK for male pattern hair loss. It works by inhibiting the enzyme 5-alpha reductase, thereby reducing DHT levels and slowing follicle miniaturisation. Finasteride is not licensed for use in women. Women who are pregnant or may become pregnant must not handle crushed or broken finasteride tablets, as the medicine can be absorbed through the skin and may harm a male foetus.

The MHRA has issued important safety information regarding finasteride. Side effects, though uncommon, can include reduced libido, erectile dysfunction, and ejaculatory disorders. There have also been reports of depression, anxiety, and suicidal thoughts in men taking finasteride. Some men have reported that sexual and psychiatric side effects persisted after stopping the medicine. Patients are advised to carry the patient alert card provided with their prescription. If you experience mood changes, low mood, or thoughts of self-harm whilst taking finasteride, stop the medicine and seek medical advice immediately. Finasteride can also lower PSA (prostate-specific antigen) levels, which is relevant for men undergoing prostate monitoring; inform any clinician requesting a PSA test that you are taking finasteride. Discuss all risks and benefits with your prescribing doctor before starting treatment.

For alopecia areata, the British Association of Dermatologists (BAD) guidelines support the use of potent topical corticosteroids as a first-line treatment, with intralesional steroid injections considered in more persistent cases. JAK inhibitors have received MHRA licensing for severe alopecia areata in adults; NHS commissioning and eligibility criteria vary, and these treatments are initiated by specialists only. Patients should refer to current NICE Technology Appraisals and local commissioning policies for up-to-date information.

It is important to have realistic expectations: most treatments slow or halt further loss rather than fully restoring previous hair density. Treatments such as platelet-rich plasma (PRP) and low-level laser therapy have mixed evidence and are not routinely NHS-funded. Hair transplant surgery is available privately in the UK but is not routinely funded by the NHS.

Lifestyle Changes That May Help Slow Crown Hair Loss

A balanced diet adequate in iron, zinc, and protein, avoiding tight hairstyles and crash dieting, managing stress, and avoiding smoking and anabolic steroids can support follicle health and may help slow crown hair loss progression.

Whilst lifestyle changes alone are unlikely to reverse established androgenetic alopecia, there is good evidence that certain habits can support overall scalp and follicle health, potentially slowing the progression of crown of head hair loss and improving the condition of existing hair.

Nutrition plays a meaningful role. Ensuring adequate intake of key nutrients — particularly iron, zinc, vitamin D, and protein — supports the hair growth cycle. A balanced diet rich in leafy greens, eggs, oily fish, nuts, and lean protein provides many of these micronutrients naturally. Crash dieting or very low-calorie intake is a well-recognised trigger for telogen effluvium, so gradual, sustainable weight management is advisable.

Routine supplementation with micronutrients is not recommended unless a deficiency has been confirmed by a blood test and discussed with your GP. Excessive zinc supplementation can cause copper deficiency. High-dose biotin (vitamin B7) supplements should be used with particular caution: biotin deficiency is rare, and high doses can interfere with a number of laboratory tests — including thyroid function tests and cardiac troponin assays — potentially producing misleading results. If you are taking biotin supplements, inform your GP or any clinician requesting blood tests. The MHRA has issued guidance on this risk.

Stress management is also relevant. Chronic psychological stress has been associated with telogen effluvium and may exacerbate autoimmune hair conditions. Techniques such as regular physical activity, mindfulness, adequate sleep, and, where appropriate, psychological support can help regulate the body's stress response.

Additionally, consider the following practical measures:

• Avoid tight hairstyles (such as tight ponytails, buns, or braids) that place traction on the crown, as these can contribute to traction alopecia over time

• Handle hair gently — minimise excessive heat styling, chemical treatments, and vigorous towel drying

• Use a mild shampoo suitable for your scalp type; if seborrhoeic dermatitis is present, a medicated shampoo containing ketoconazole 2%, selenium sulphide, coal tar, or ciclopirox may be beneficial — your GP or pharmacist can advise on currently available options

• Avoid smoking, as observational evidence suggests an association between smoking and accelerated androgenetic alopecia

• Avoid anabolic steroids and certain bodybuilding supplements, as these may worsen androgenetic alopecia

It is worth noting that there is no established link between wearing hats and crown hair loss — this is a common misconception. If you are uncertain whether a supplement or product is appropriate for your situation, consult your GP or a qualified trichologist before use.

Frequently Asked Questions